CIRCON CORP
10-Q, 1996-05-15
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: ILC TECHNOLOGY INC, 10-Q, 1996-05-15
Next: KLEER VU INDUSTRIES INC/DE/, 10-Q, 1996-05-15



                                 FORM 10-Q

                    SECURITIES AND EXCHANGE COMMISSION

                          WASHINGTON, D.C.  20549



QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

FOR QUARTER ENDED    March 31, 1996              COMMISSION FILE NO.  0-12025 


CIRCON CORPORATION                                                          
(Exact Name of Registrant as Specified in Its Charter)


         Delaware                                        95-3079904         
(State or other jurisdiction of                        (I.R.S. Employer
 incorporation or organization)                         Identification No.)



6500 Hollister Avenue, Santa Barbara, California       93117-3019           
(Address of Principal Executive Offices)               (Zip Code)


Registrant's telephone number, including area code:  (805) 685-5100         


          Indicate by check mark whether the registrant (1) has
          filed all reports required to be filed by Section 13
          or 15(d) of the Securities Exchange Act of 1934
          during the preceding twelve months (or for such shorter
          period that the registrant was required to file such
          reports), and (2) has been subject to such filing 
          requirements for the past 90 days.

                         Yes  X         No    


Number of Common Shares Outstanding at March 31, 1996:   12,574,196       



                                     

                  CIRCON CORPORATION AND SUBSIDIARIES

                        CONSOLIDATED BALANCE SHEETS

                  DECEMBER 31, 1995 AND MARCH 31, 1996

                                        ASSETS

                    (In thousands, except for share amounts)
                                                       
                                                                (UNAUDITED)
                                                December 31,      March 31,
                                                       1995           1996
                                                 -----------     -----------
CURRENT ASSETS:
     Cash and temporary cash investments       $    17,586      $    8,292
     Marketable securities                           6,496             585
     Accounts receivable, net of allowance of
     $1,807 in 1995 and $1,814 in 1996              26,539          27,569
     Inventories                                    31,645          32,648
     Prepaid expenses and other assets               2,627           3,412
     Deferred income taxes                           5,932           5,932
                                                -----------      ----------  
          Total current assets                      89,233          78,438


PROPERTY, PLANT, AND EQUIPMENT, NET                 53,750          54,395


OTHER  ASSETS                                       36,824          36,088
                                                ----------       -----------
                      Total assets           $     181,399      $  168,921
                                                ===========      ===========   

                   The accompanying notes are an integral part of
                             these consolidated balance sheets.



                  CIRCON CORPORATION AND SUBSIDIARIES

                        CONSOLIDATED BALANCE SHEETS

                  DECEMBER 31, 1995 AND MARCH 31, 1996

                  LIABILITIES AND SHAREHOLDERS' EQUITY

               (In thousands, except for share amounts)

                                                                   (UNAUDITED)
                                                  December 31,      March 31,
                                                         1995           1996
                                                   -----------     ----------
CURRENT LIABILITIES:
     Current maturities of long-term obligations  $    15,857      $     574
     Accounts payable                                   7,728          5,426
     Accrued liabilities                               10,796         10,624
     Customer deposits                                  1,079          1,191
                                                   -----------     ----------
          Total current liabilities                    35,460         17,815

NONCURRENT LIABILITIES:
     Long-term obligations                             56,435         58,935
     Deferred income taxes                              2,251          2,608
     Capital lease obligations and other                   81             61
                                                   -----------     ----------
          Total noncurrent liabilities                 58,767          61,604


SHAREHOLDERS' EQUITY:
Preferred stock: $0.01 par value
      1,000,000 shares authorized, none 
      outstanding
Common stock: $0.01 par value
     50,000,000 shares authorized
    12,564,079 and 12,574,196  issued and outstanding
   in 1995 and 1996 respectively                         126           190
Additional paid-in capital                            94,928        94,958
Minimum pension liability                               (143)         (143)
Cumulative translation adjustment                       (513)           64
Accumulated Deficit                                   (7,226)       (5,567)
                                                   -----------    ----------    
Total shareholders' equity                            87,172        89,502

Total liabilities and shareholders'
     equity                                      $   181,399     $ 168,921
                                                  ===========     =========
                   The accompanying notes are an integral part of
                        these consolidated balance sheets.


                             CIRCON CORPORATION AND SUBSIDIARIES

                           CONSOLIDATED STATEMENTS OF OPERATIONS

                                 Three Months Ended March, 31 

                            (In thousands, except per share amounts)


                                          (UNAUDITED)           (UNAUDITED)
                                               1995                  1996
                                          ----------             ---------
NET SALES                              $     37,921         $      39,962

    Cost of sales                            17,398                17,764
                                          ----------             ---------
GROSS PROFIT                                 20,523                22,198


OPERATING EXPENSES:
     Research and development                2,612                  2,975
     Selling, general and administrative    15,844                 15,645
                                         ----------             ----------   
     Total operating expenses               18,456                 18,620

INCOME FROM OPERATIONS                       2,067                  3,578

     Interest income                           363                     95
     Interest expense                       (1,440)                (1,128)
     Other income (expense), net                53                    (62)
                                         ----------             ------------
INCOME  BEFORE PROVISION FOR INCOME TAXES    1,043                  2,483

     Provision  for income taxes               370                    824
                                         ----------             -----------
NET INCOME                             $       673            $     1,659
                                         ==========             ===========    

EARNINGS  PER SHARE                    $      0.07            $      0.13
                                         ==========             ===========
Weighted Average Number of Shares of Common
Stock and Equivalents Outstanding           12,778                 13,114
                                         ==========              ==========

                           The accompanying notes are an integral part of
                                     these consolidated statements.




                  CIRCON CORPORATION AND SUBSIDIARIES

                 CONSOLIDATED STATEMENTS OF CASH FLOWS

                     Three Months Ended March, 31

                             (In Thousands) 



CASH FLOWS FROM OPERATING ACTIVITIES                   1995        1996
                                                    --------     -------

  Net income                                            673       1,659

  Adjustments to reconcile net
      income  to cash provided by (used in)
      operating activities:

     Depreciation and amortization                    2,476       2,380
     Deferred income taxes                              (40)        310


Change in assets and liabilities:
     Accounts receivable                                394      (1,030)
     Inventories                                       (935)     (1,003)
     Prepaid expenses and other assets                 (148)       (785)
     Other assets                                       272         123
     Accounts payable                                   810      (2,302)
     Accrued liabilities                             (1,706)       (172)
     Customer deposits                                   13         112
                                                    ---------   ---------       
Net cash provided by (used in) operating activities   1,809        (708)
                                                    ---------   ---------




                               CIRCON CORPORATION AND SUBSIDIARIES

                               CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   Three Months Ended March, 31
 
                                          (In Thousands)


CASH FLOWS FROM INVESTING ACTIVITIES                        1995       1996
                                                         --------    --------
     Disposals of marketable securities, net                 318       5,911
     Purchases of property, plant and equipment           (3,549)     (2,365)
     Cumulative translation adjustment                       448         577
                                                         --------    --------
     Net cash provided by (used in) investing activities  (2,783)      4,123
                                                         --------    --------
CASH FLOWS FROM FINANCING ACTIVITIES

     Proceeds from issuance of common stock                  151          82
     Repayments of capital lease obligations                (135)        (20)
     Repayments of long-term obligations                    (362)    (12,783)
     Tax benefit from exercise of stock options              244          12
     Other                                                  (149)          0
                                                         ---------   --------
    Net cash used in financing activities                   (251)    (12,709)
                                                         ---------   --------  
     Net decrease in cash and temporary
     cash investments                                     (1,225)     (9,294)

  Cash and temporary cash investments, beginning
     of period (reflects Cabot cash as of Dec 31, 1995)    2,882      17,586
                                                         ---------   -------- 
  Cash and temporary cash investments, end of period   $   1,657   $   8,292
                                                         =========   ======== 
SUPPLEMENTAL DISCLOSURES

     Cash paid for interest                            $   2,592   $      66
                                                         ========    ======== 
     Cash paid for income taxes                        $     176   $     274
                                                         ========    ========

                           The accompanying notes are an integral part of
                                    these consolidated statements.





                        CIRCON CORPORATION

       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                          MARCH 31, 1996

General

    The accompanying condensed consolidated financial statements
include the accounts of Circon Corporation (the Company) and its
subsidiaries, Cabot Medical (a U.S. corporation), Circon GmbH (a German 
corporation), Circon Canada Inc. (a Canadian corporation) and Circon Export
Corporation, which operates as a Foreign Sales corporation (FSC) under 
federal income tax laws.  All significant intercompany transactions and accounts
have been eliminated in consolidation.

    The condensed consolidated financial statements included herein
have been prepared by the Company, without audit, in accordance with generally 
accepted accounting principles for interim financial information and with the
instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  It is suggested
that these condensed consolidated financial statements be read in conjunction
with the statements and notes thereto included in the Company's annual report
for the year ended December 31, 1995, and Form S-4 filed in connection with 
the Cabot business combination.

    On August 28, 1995, Circon Corporation ("Circon") merged with
 Cabot Medical Corporation ("Cabot"), collectively referred to as "the
Company," in a transaction accounted for as a pooling of interests.  Circon's
consolidated financial statements have been restated for all periods prior to
the merger to include the financial position, results of operations and cash
flows of Cabot.

    The information reflects all adjustments (consisting only of normal
recurring adjustments and the restatement for the Cabot business combination) 
which are, in the opinion of management, necessary for a fair presentation of
the financial position and the results of operations for the interim periods. 
The results for the interim periods are not necessarily indicative of the
results expected for any other period or for the entire year.

(1) Inventories
    -----------

  Inventories include costs of materials, labor and manufacturing
overhead and are priced at the lower of cost (first-in, first-out) or market.
Inventories at December 31, 1995 and March 31, 1996 consist of the
following:

                                                  1995            1996     
                                              ----------      ---------  
    Raw materials                             $  11,017       $  10,942
    Work in process                              12,243          11,957
    Finished goods                                8,385           9,749
                                              ----------      ---------
                                              $  31,645       $  32,648
                                              ==========      =========

(2) Long-Term Obligations
    --------------------

    Long-term obligations as of December 31, 1995 and March 31, 1996 consist
of the following:

                                                       1995       1996  
                                                   ---------  --------
     Note payable to bank under a revolving
       line of credit of $75,000,000, secured
       by substantially all of the company's
       assets, with interest at 0.95 points
       above the Eurodollar rate (6.325% at
       March 31, 1996).                           $     -    $  54,500 

     7.5% convertible subordinated notes             67,000        -       

     Industrial development authority bonds
       due December 2, 2006                           5,180      4,950 

     Other                                              112         59 

     Less: current maturities                       (15,857)      (574)
                                                   ---------    --------
                                                  $  56,435   $  58,935 
                                                   =========    ========

     The Company has a $75 million revolving credit facility (the "Credit
Facility") which provides for direct borrowings and a maximum of $5 million
in letters of credit.  The Company has the option to borrow money based
upon (I) the higher of the prime rate or an adjusted federal funds rate or
(ii) an adjusted eurodollar rate.  The unused portion of the Credit
Facility has a commitment fee which ranges from .1875% to .375%. 
The Credit Facility, which expires August 1, 2001, contains certain
restrictive financial covenants and is secured by substantially all of
the assets of the Company.

     The Company has a letter of credit facility in the amount of
approximately $5,327 as of March 31, 1996 underlying $7,000 of tax
exempt Industrial Development Authority Bonds (the "Bonds") issued
in December 1991 with a 15 year maturity requiring monthly interest
payments and annual principal payments.  The letter of credit has a 
renewable 5 year term and carries an annual fee of 1% of the 
outstanding bond principal amount.  The bonds are subject  to weekly
repricing at an interest rate based on the remarketing agents' 
professional judgment and prevailing market conditions at the time. 
The Bonds and the letter of credit facility are collateralized by the
Company's two Langhorne, Pennsylvania operating facilities.  These
facilities had a net carrying value of $5,181 as of March 31, 1996.

     During the first quarter of 1996 the Company repurchased all
but $39,000 of the $67,000,000 convertible notes.  In April the Company 
repurchased the remaining $39,000 of the convertible note.   Approximately
$54.5 million of the Credit Facility and $12.5 million of available
cash was used to repurchase these notes.

     Future principal maturities of the Industrial Development Bonds
and the Credit Facility are as follows:

      1996       $    574                             
      1997            370
      1998            390
      1999            405
      2000            430
      Thereafter   57,340
                 ---------
                $ 59,509
                 =========





ITEM 2.   Management's Discussion and Analysis of Operations and Financial
          Condition

     RESULTS OF OPERATIONS
     ---------------------


               Three Months Ended March 31, 1996
         Compared to Three Months Ended March 31, 1995

     Sales
     -------

     Total sales of $40.0 million were up 5.4% over first quarter 1995. 
U.S. sales force sales and international sales increased 9% and 7%, 
respectively.  These were partially offset by a 19% decrease in dealer
sales and a 16% decrease in industrial sales.  Price increases accounted
for 1% of the sales increase.

     Gross Profit
     -------------
     First quarter gross profit totaled $22.2 million or 55.5% of sales
compared to $20.5 million or  54.1% for the same period last year.
The improvement was the result of increased manufacturing efficiencies
and sales of higher margin products.

     Operating Expense
     -----------------
     Total operating expenses increased 1% over first quarter 1995 as
compared to a 5.4% sales increase.  Selling and general administrative
expense decreased 1.2% reflecting economies gained from the merger
of Circon and Cabot.

     Research and development expenditures totaled $3.0 million, up
14% over prior year reflecting continued emphasis on new product 
development.  As a percent of sales, R&D expense was 7.4% compared
to 6.9% for prior year.

     Income from Operations
     -----------------------
     Operating income was up 73% to $3.6 million due to increased
sales and gross profits and operating expense trends discussed above.

     Interest and Other Expense
     --------------------------
     Interest expense of $1,128,000 decreased $312,000 from prior year
due to reduced loan balances.  Interest income of $95,000 decreased
$268,000 from prior year due to lower investment balances.

     Income Taxes
     -------------
     The provision for income taxes of 33% compared to 35.5% in 1995
decreased due to the ability of the company to utilize some of the NOL from
 Cabot.

     Net Income
     -----------
     Net income of $1.7 million was up 147% over comparable 1995 due
to increased sales and higher profit margins.

     Subsequent Events
     ------------------
     The company will be closing Cabot Medical's smaller facility in
Langhorne, Pennsylvania, and taking other consolidating actions by the end
of the third quarter 1996.  As a result of this consolidation and related tax
benefits, Circon is targeting after tax benefits of $0.8 million in 1996,
(including a credit of approximately $2.0 million to the provision for income
taxes resulting from the liquidation of Cabot and related realization of
Cabot tax benefits), $1.8 million in 1997 and each subsequent year
compared to not taking these actions.  The targeted one time operating cost,
associated with closing the facility, is $1.8 million in 1996, but will yield
$2.6 million in operating cost savings in 1997 and each subsequent year 
compared to not consolidating.

     This consolidation is targeted to produce a $0.8 million benefit in
the second quarter, (including a credit of approximately $2.0 million to the
provision for income taxes resulting from the liquidation of Cabot and 
related realization of Cabot tax benefits), a $0.2 million cost in the third
quarter and a benefit of $0.2 million in the fourth quarter, for a full year
1996 after tax benefit of $0.8 million.  In the years 1997 and beyond, the
after tax benefit is targeted for $0.45 million per quarter or $1.8 million
per year.

     The major costs associated with closing the facility and relocating
the production activities are targeted to occur in the second quarter and
total $1.8 million for 1996.  By the fourth quarter, operating savings of
$0.3 million are targeted.  In the years 1997 and beyond, this consolidation
is targeted to produce operational savings of $0.65 million per quarter
or $2.6 million per year.


                Liquidity and Capital Resources
               --------------------------------  
     Circon has a $75.0 million secured revolving credit line with a 
syndicate of banks. $50.5 million of this facility was used to repurchase
Cabot notes in January 1996 (see note 2).

     As of March 31, 1996, the company had cash and marketable
securities totaling  $8.9 million.

     The company believes that cash flow from operations, existing
cash and marketable securities and available cash from bank credit 
facilities are adequate to fund the company's existing operation for the
foreseeable future.


                            SIGNATURES





Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned thereunto
duly authorized.

                                                    CIRCON CORPORATION
                                                    Registrant



 May 14, 1996                                                    
 ------------                             -----------------
 Date                                     RICHARD A. AUHLL
                                          President
                                          Chief Executive Officer





 May 14, 1996                                                   
 ------------                             -----------------
 Date                                     R. BRUCE THOMPSON
                                          Executive Vice President
                                          Chief Financial Officer


[TYPE]EX-27
[ARTICLE] 5
[LEGEND]
The user should be aware that this document is NOT complete, and should refer
to the 10-Q for a complete set of financial information.
[/LEGEND]
<TABLE>
<S>                            <C>
[PERIOD-TYPE]                 3-MOS
[FISCAL-YEAR-END]                         DEC-31-1996
[PERIOD-END]                              MAR-31-1996
[CASH]                                      8,292,000                            
[SECURITIES]                                  585,000
[RECEIVABLES]                              29,383,000
[ALLOWANCE]                                 1,814,000 
[INVENTORY]                                32,648,000
[CURRENT-ASSETS]                           78,438,000
[PP&E]                                     88,395,000
[DEPRECIATION]                             34,000,000 
[TOTAL-ASSETS]                            168,921,000
[CURRENT-LIABILITIES]                      17,815,000
[BONDS]                                             0
[COMMON]                                   95,148,000
[PREFERRED-MANDATORY]                               0
[PREFERRED]                                         0
[OTHER-SE]                                    (79,000) 
[TOTAL-LIABILITIES-AND-EQUITY]            168,921,000
[TOTAL-REVENUES]                           39,962,000 
[CGS]                                      17,764,000
[TOTAL-COSTS]                              18,620,000 
[OTHER-EXPENSES]                               62,000
[LOSS-PROVISION]                                    0 
[INTEREST-EXPENSE]                          1,128,000 
[INCOME-PRETAX]                             2,483,000
[INCOME-TAX]                                  824,000
[INCOME-CONTINUING]                         1,659,000
[DISCONTINUED]                                      0
[EXTRAORDINARY]                                     0
[CHANGES]                                           0
[NET-INCOME]                                1,659,000    
[EPS-PRIMARY]                                    0.13
[EPS-DILUTED]                                    0.13
</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission